H
Hirohiko Kamiyama
Researcher at Johns Hopkins University
Publications - 7
Citations - 3908
Hirohiko Kamiyama is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Gene mutation & Gene. The author has an hindex of 6, co-authored 6 publications receiving 3668 citations.
Papers
More filters
Journal ArticleDOI
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones,Xiaosong Zhang,D. Williams Parsons,D. Williams Parsons,Jimmy Lin,Rebecca J. Leary,Philipp Angenendt,Parminder Mankoo,Hannah Carter,Hirohiko Kamiyama,Antonio Jimeno,Seung-Mo Hong,Baojin Fu,Ming Tseh Lin,Eric S. Calhoun,Mihoko Kamiyama,Kimberly Walter,Tatiana Nikolskaya,Yuri Nikolsky,James Hartigan,Douglas Smith,Manuel Hidalgo,Steven D. Leach,Alison P. Klein,Elizabeth M. Jaffee,Michael Goggins,Anirban Maitra,Anirban Maitra,Christine A. Iacobuzio-Donahue,James R. Eshleman,Scott E. Kern,Ralph H. Hruban,Rachel Karchin,Nickolas Papadopoulos,Giovanni Parmigiani,Bert Vogelstein,Victor E. Velculescu,Kenneth W. Kinzler +37 more
TL;DR: It is found that pancreatic cancers contain an average of 63 genetic alterations, the majority of which are point mutations, which defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.
Journal ArticleDOI
KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
Chanjuan Shi,Seung-Mo Hong,Phillip Lim,Hirohiko Kamiyama,Mehtab Khan,Robert A. Anders,Michael Goggins,Ralph H. Hruban,James R. Eshleman +8 more
TL;DR: Isolated AMD lesions are genetically distinct from those associated with PanINs, and the latter may represent retrograde extension of the neoplastic PanIN cells or less likely are precursors to PanIN.
Journal ArticleDOI
Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.
Ming Tseh Lin,Li Hui Tseng,Li Hui Tseng,Hirohiko Kamiyama,Mihoko Kamiyama,Phillip Lim,Manuel Hidalgo,Sarah J. Wheelan,James R. Eshleman +8 more
TL;DR: A molecular assay to quantify the relative contributions of human and mouse in mixed DNA samples is developed and how contaminating mouse DNA affects next-generation DNA sequencing is discussed.
Journal ArticleDOI
Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
Hirohiko Kamiyama,Sherri Rauenzahn,Joong Sup Shim,Collins Karikari,Georg Feldmann,Li Hua,Mihoko Kamiyama,F. William Schuler,Ming Tseh Lin,Robert Beaty,Balasubramanyam Karanam,Hong Liang,Michael Mullendore,Guanglan Mo,Manuel Hidalgo,Elizabeth M. Jaffee,Ralph H. Hruban,H. A. Jinnah,Richard B.S. Roden,Antonio Jimeno,Jun O. Liu,Anirban Maitra,James R. Eshleman +22 more
TL;DR: Chemotherapy can be personalized using patient-specific cell lines derived in biochemically selectable mice, as shown by high-throughput chemosensitivity testing of low-passage cancer cell lines from primary cancers.
Journal ArticleDOI
In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.
Hirohiko Kamiyama,Mihoko Kamiyama,Seung-Mo Hong,Collins Karikari,Ming Tseh Lin,Michael Borges,Margaret Griffith,Angela Young,Alexis Norris-Kirby,Conrad Lubek,Masamichi Mizuma,Georg Feldmann,Chanjuan Shi,Hong Liang,Michael Goggins,Anirban Maitra,Ralph H. Hruban,James R. Eshleman +17 more
TL;DR: In vivo and in vitro growth of selected IPMNs were attempted based on the hypothesis that IPMNs could be grown in the most severely immunodeficient mice, and one IPMNs, with an associated invasive carcinoma, was successfully established as a cell line.